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Abstract: The effects of polyphenol-rich foods on the iron status of athletes, as well as the
effect of physical training on the hormone hepcidin, implicated in iron metabolism, are not clear.
We investigated the influence on iron metabolism of a long-term training intervention of 120 days,
measuring the hepcidin concentration in the plasma of 16 elite triathletes, and the effect of the
ingestion of 200 mL of either aronia-citrus juice or a placebo drink for 45 days, in a crossover
design. The highest plasma hepcidin concentrations were observed at the beginning of the study
(116± 63 nM) and levels steadily decreased until the end of the intervention (final value 10± 7.5 nM).
Long-term training might reduce inflammation and, hence, could be responsible for the decrease
in hepcidin in triathletes. Polyphenols from aronia-citrus juice did not interfere in iron absorption,
as we did not observe significant differences between the intake of the placebo drink or juice with
regard to hepcidin levels. Further studies are required to ascertain the time and conditions necessary
to restore hepcidin levels, which reflect the iron status of triathletes.
Keywords: polyphenols; hepcidin; iron; exercise; juice
1. Introduction
Hepcidin is a peptide hormone synthesized mainly in the liver and the active form consists
of 25 amino acids. Some studies have demonstrated the relationship between hepcidin and iron.
Nicolas et al. observed a severe iron overload in mice that were knockout for the gene encoding
hepcidin [1]. It has also been shown that hepcidin is regulated by hemojuvelin, a protein produced in
the liver and whose gene expression is responsible for juvenile hemochromatosis, causing excessive
accumulation of iron in different organs, mainly in the liver [2], and promoting the development of
certain infectious diseases [3]. The maintenance of iron levels involves regulation of iron absorption
from the diet and its storage in hepatic and splenic macrophages. During absorption, iron is taken up by
enterocytes, where it will bind to ferroportin or be incorporated into intracellular ferritin for storage [4,5].
Hepcidin has been shown to have its main role in iron homeostasis, as it regulates transmembrane iron
transport. It binds to the cell surface receptor, ferroportin, which is then internalized and digested by
lysosomes. Ferroportin enables iron flux from enterocytes, hepatocytes, and macrophages into blood.
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Hence, the decrease in ferroportin levels in enterocytes due to hepcidin action leads to decreased
iron absorption in hepatocytes and macrophages, due to a reduction in iron recycling from senescent
erythrocytes, and to low serum iron levels.
Some studies have shown the relationship between physical activity and iron absorption. In rats
it has been observed that intense exercise decreases the absorption of iron [6]. Studies in humans have
shown increased prevalence of a deficient iron status in athletes that may affect up to one-third of the
population of athletes [7]. Inadequate body iron stores may decrease physical performance. This effect
should not be confused with sport anemia—which is more frequent in endurance athletes, being
named “runner’s anemia” or “swimmer’s anemia”. In this case, training produces a rapid expansion
of plasma volume and a slow expansion of the red blood cells, which explains the transient decrease in
the hematocrit, especially in the early stages of training [8].
The deficient iron status mentioned before has been attributed to several factors, including
increased destruction of red blood cells via foot-strike, hemolysis, inadequate dietary intake of iron,
iron loss via sweating, and gastrointestinal blood loss [9]. In recent years, the discovery of the
iron regulatory hormone hepcidin revealed another possible cause of iron deficiency. Furthermore,
it has been observed that various factors, such as hypoxia, inflammation, and iron level, are able to
regulate hepcidin levels [10]. A relationship between hepcidin and inflammation has been described,
with a response similar to the acute phase of inflammation frequently observed after acute exercise.
In response to inflammation, the hepcidin concentration increases in order to reduce or limit the
iron available to invading pathogenic microorganisms [11]. Some studies have investigated the
connections between inflammatory processes and hepcidin levels [12,13]. In 2006, Wrighting and
Andrews demonstrated that the inflammatory cytokine interleukin-6 (IL-6) regulated hepcidin through
induction and subsequent promoter binding of the signal transducer and activator of transcription 3
(STAT3). In fact, IL-6 is the main stimulator of hepcidin synthesis [3,12,13]. In athletes, the use of
dietetic supplementation, primarily to prevent deleterious effects of exercise, is very common [14].
Phytochemical compounds, such as flavonoids, might provide health benefits with regard to
sport, but studies on the efficiency of polyphenol-rich foods in relation to iron absorption in this type
of population are scarce. We have previously observed an increase in the bioavailability of flavanones
from a citrus-based juice after exercise, which could provide positive effects for health [15]. On the
other hand, limited information is available on the impact of nutritional intervention on the novel
hormone hepcidin and the ferric status of athletes.
The aim of the present study is to investigate a citrus-based juice, rich in polyphenols and
vitamin C, along with long-term exercise affect iron status, considering changes in serum hepcidin
levels, in a sample of elite triathletes.
2. Results
The mass spectrometer (MS) parameters (ion optics; capillary exit voltage) were optimized at
a hepcidin concentration of 10 µM. The fragmentor and collision energy conditions were calculated
for [M + 4H]4+ m/z 698.1, m/z 703.2, and [M + 5H]5+ m/z 558.7, m/z 562.8 for hepcidin and the
[13C18, 15N3]-hepcidin standard, respectively. These were found to be the most intense ions,
in accordance with Bansal et al. [16]. We selected the transitions 698.1 → 86.1 and 562.8 → 70.2
to quantify hepcidin levels in the plasma samples of triathletes. Figure 1 shows the chromatograms of
both the 10 nM hepcidin standard and the endogenous hepcidin present in the samples. The highest
plasma concentrations of hepcidin were recorded at the beginning of the study, with a mean value of
116.6 ± 63.3 nM (baseline control with mild exercise and a mean ECO (Equivalentes de Carga Objetiva,
Objective-Load Scale) value of 37.5). Afterwards, hepcidin levels decreased steadily until the end of
the study period. In fact, after two weeks of intensified training (control 2, mean ECO value of 1008)
a mean hepcidin concentration of 78.7 ± 71.1 nM was found (Table 1). The levels markedly decreased
during the nutritional intervention with drinks, irrespective of the treatment (mean values of 15.2 nM
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for the placebo drink and 29.4 nM for the aronia-citrus juice drink). The hepcidin concentrations
diminished to a mean value of 10 nM in the final control samples.Molecules 2016, 21, 1333 3 of 13 
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Baseline Control 116.6 63.3 78.29–154.83 
Control 2-Exercise 78.7 71.1 44.23–124.91 
Placebo Juice 15.2 12.6 5.60–38.04 
Aronia-Citrus juice 29.4 19.6 18.61–40.27 
Final Control 10.0 7.5 5.78–14.12 
The confidence intervals show a high variability in the results due to inter-individual differences. 
The Levene test did not show homogeneity of variance and, hence, we performed a non-parametric 
statistical analysis. 
A description of the distribution of data is shown in the box plots diagram (Figure 2). 
The Wilcoxon test revealed that the changes in hepcidin concentration were of statistical 
significance for the placebo treatment and baseline control (p = 0.005) and for the control 2-exercise  
(p = 0.005). The final control group showed statistical significance for the baseline control (p = 0.002) 
and for the control 2-exercise (p = 0.004). The aronia-citrus juice (ACJ) treatment produced a slight 
difference when compared to the baseline control and control 2, although non-significant differences 
were observed between the two test drinks. 
Figure 1. (A) Hepcidin standard at a concentration of 10 nM; and (B) endogenous hepcidin in
a plasma sample.
Table 1. Plasma concentrations of hepcidin in the different stages of the study. Data are shown in nM
as mean ± standard deviation. Confidence intervals (CI) are included.
Groups Mean STD Confidence Intervals (CI)
Baseline Control 116.6 63.3 78.2 –154.83
Control 2-Exercise 78.7 71.1 44.23–124.91
Placebo Juice 15.2 12.6 5.60–38.04
Aronia-Citrus juice 29.4 19.6 18.61–40.27
Final Control 10.0 7.5 5.78–14.12
The confidence intervals show a high variability in the results due to inter-individual differences.
The Levene test did not show homogeneity of variance and, hence, we performed a non-parametric
statistical analysis.
A description of the distribution of data is shown in the box plots diagram (Figure 2).
The Wilcoxon test revealed that the changes in hepcidin concentration were of statistical
significance for the placebo treatment and baseline control (p = 0.005) and for the control 2-exercise
(p = 0.005). The final control group showed statistical significance for the baseline control (p = 0.002)
and for the control 2-exercise (p = 0.004). The aronia-citrus juice (ACJ) treatment produced a slight
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difference when compared to the baseline control and control 2, although non-significant differences
were observed between the two test drinks.Molecules 2016, 21, 1333 4 of 13 
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would probably have been followed by inhibition of both intestinal iron absorption and the release 
of iron from macrophages, both contributing to the development of iron deficiency in these athletes. 
Peeling et al. [22] examined the urinary hepcidin levels, inflammation process (the interleukin 6 and 
C-reactive protein levels), and iron metabolism during the 24 h after exercise. They concluded that 
high-intensity exercise was responsible for a significant increase in hepcidin levels, subsequent to a 
significant increase in IL-6 and serum iron. In the case of acute exercise, a relationship between this 
exercise modality and the acute phase response of inflammation has been demonstrated. This type 
of response is a complex of physiological processes occurring in response to some threats within the 
body, such as infection, trauma, the inflammatory process, strenuous exercise, or tissue injury [9]. 
The effects of chronic exercise on hepcidin levels have been studied less; there may be a 
tendency of the hormone concentrations to decrease. It seems that the duration of the training is not 
the most influential factor; rather, it is the volume of training (frequency, intensity) that has a major 
impact on iron levels. The maximum oxygen consumption (VO2 max) is defined as the highest rate of 
oxygen consumption that athletes may utilize during intense or maximal exercise. Dominguez et al. 
[23] proposed that an intensity of VO2 max lower than 65% is not enough to trigger a response in iron 
metabolism and that higher values would start to increase hepcidin levels and impede iron 
absorption. 
Our study is based on sport training for 120 days. We did not determine the hepcidin levels 
after a bout of exercise, but we took samples under resting conditions—in a context of long-term, 
regular exercise by our elite athletes, with a constant, mild intensity—and not in bouts of exercise 
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Figure 2. Hepcidin levels (nM) determined in plasma samples of triathletes following the training
and nutritional intervention program. Box plots with quartiles (upper values, 75%; median, 50%; and
lower values, 25%). Friedman′s ANOVA and post hoc analysis with Wilcoxon signed-rank tests (with
a Bonferroni correction) were conducted (p < 0.005).
3. Discussion
We have determined the effect of exercise and the consumption of a polyphenol-rich beverage
on hepcidin levels in triathletes. Our data show a decrease in plasma hepcidin concentrations in
the triathletes after a training schedule. Major regulation of hepcidin levels results from the high
production of pro-inflammatory cytokines, such as IL-6, hypoxic conditions, and plasma iron levels [10].
Concerning exercise, the intensity of training is a crucial factor influencing iron metabolism and
hepcidin. Some authors have investigated the influence of both chronic and acute physical exercise
on hepcidin [17–19]. In most studies of acute exercise, hepcidin levels increased: during military
training [20], in rowers [21], or in female runners after a marathon [18]. This effect was associated
with increases in inflammation and hemolysis induced by exercise [18]. The increase in hepcidin
would probably have been followed by inhibition of both intestinal iron absorption and the release
of iron from macrophages, both contributing to the development of iron deficiency in these athletes.
Peeling et al. [22] examined the urinary hepcidin levels, inflammation process (the interleukin 6 and
C-reactive protein levels), and iron metabolism during the 24 h after exercise. They concluded that
high-intensity exercise was responsible for a significant increase in hepcidin levels, subsequent to
a significant increase in IL-6 and serum iron. In the case of acute exercise, a relationship between this
exercise modality and the acute phase response of inflammation has been demonstrated. This type
of response is a complex of physiological processes occurring in response to some threats within the
body, such as infection, trauma, the inflammatory process, strenuous exercise, or tissue injury [9].
The effects of chronic exercise on hepcidin levels have been studied less; there may be a tendency
of the hormone concentrations to decrease. It seems that the duration of the training is not the most
influential factor; rather, it is the volume of training (frequency, intensity) that has a major impact on
iron levels. The maximum oxygen consumption (VO2 max) is defined as the highest rate of oxygen
consumption that athletes may utilize during intense or maximal exercise. Dominguez et al. [23]
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proposed that an intensity of VO2 max lower than 65% is not enough to trigger a response in iron
metabolism and that higher values would start to increase hepcidin levels and impede iron absorption.
Our study is based on sport training for 120 days. We did not determine the hepcidin levels after
a bout of exercise, but we took samples under resting conditions—in a context of long-term, regular
exercise by our elite athletes, with a constant, mild intensity—and not in bouts of exercise that typically
produce an increase in hepcidin levels. This is consistent with a study describing the effects of eight
weeks of endurance running in female runners [24]. These authors analyzed the relationships among
long-term exercise, hepcidin, and biomarkers of inflammation in a sample of 14 runners. In their
study, serum hepcidin concentrations tended to decline during the running training and they did not
find any change in C-reactive protein, used as a biomarker of inflammation. In this sense, we have
previously reported the levels of different biomarkers of oxidative stress and inflammation in our
triathletes [25]. The inflammation biomarkers tetranor-PGEM (tetranor prostaglandin E metabolite)
and 11β-PGF2α (11 β-prostaglandin F2α metabolite) showed lower concentrations after the training
program. If we consider the concept of the acute phase response, mentioned above, we may establish
a connection between biomarkers of inflammation, acute exercise, and chronic exercise. The intensity
of acute exercise can trigger an inflammatory response, as well as an increase in hepcidin levels. On the
other hand, in long-term or chronic exercise, the body does not respond in the same way. It seems
that, in our study, there was no inflammatory response to chronic exercise and this could explain the
decrease in the levels of hepcidin. Kapasis et al. [26] also reported a reduction in inflammation with
chronic training, due to the reduced release of pro-inflammatory cytokines, an increase in insulin
sensitivity, an improvement of endothelial function, and a reduction in body weight.
As we mentioned before, the objective of this study was to determine the effects of the
consumption of ACJ and chronic exercise on hepcidin levels—which can reflect iron status.
We observed a slight and non-significant increase in hepcidin levels in the period of ACJ consumption,
but these values did not differ statistically from those obtained with placebo ingestion. We know that
the use of some supplements, as well as certain foods, may influence iron absorption, in contrast with
the small and non-significant changes in hepcidin that we observed. Our ACJ is rich in polyphenol
compounds, such as anthocyanins, as well as being a good source of ascorbic acid [27]. It has been
demonstrated that polyphenols from the diet—found primarily in fruits and vegetables, spices, pulses,
and cereals, and being especially abundant in tea, coffee, and red wine—reduce the absorption of iron
in a dose-dependent manner. After the ingestion of foods containing phenolic compounds, these may
form complexes with iron—impeding its absorption in the intestine [28,29]. Polyphenols are easily
deprotonated at physiological pH levels in the presence of iron and form very stable complexes [30].
Metal ions with octahedral geometry, such as Fe2+ and Fe3+, can coordinate up to three catecholate
or gallate groups, as reported in the excellent review of the basis of polyphenol compounds and iron
binding by Perron and Brumaghim [31]. In a previous study conducted with beverages having different
polyphenol concentrations, the more concentrated drinks, containing 100–400 mg of total polyphenols,
reduced iron absorption by 60%–90%, whereas the drinks containing lower levels of polyphenols
(20–50 mg) reduced iron absorption by 50%–70% [28]. In contrast, we did not observe changes in the
levels of this hormone implicated in iron metabolism after the ingestion of our polyphenol-rich juice at
the selected dosage (200 mL).
On the other hand, ascorbic acid is a potent promoter of iron absorption [32]. Dietary iron needs
to be reduced from its ferric form (Fe3+) to the ferrous form (Fe2+) in order to be absorbed [33]. Thus,
one of the routes to increase the absorption of iron is the consumption of reducing agents, such as
ascorbic acid. It has been shown that ascorbic acid prevents the dose-dependent inhibitory effects
of polyphenols (measured as tannic acid), as well as those of phytates [32]. These authors observed
that ~50 mg of ascorbic acid would be necessary to improve the bioavailability of iron, to regular
values, from a meal containing more than 100 mg of polyphenols (expressed as tannic acid); they
suggested that 300 mL of orange juice would be adequate to restore the iron absorption from a meal
containing 350 mg of polyphenols. Other authors have reported that red grape and prune juices high in
Molecules 2016, 21, 1333 6 of 13
polyphenols (>1 mg/mL) limited the bioavailability of iron to human colon cancer cells and the higher
iron bioavailability was correlated with a high ascorbate/polyphenol ratio. These authors suggested
a dietary balance of juices with a high polyphenol content, as well as a high ascorbate concentration
(for proper iron absorption) [34].
The important contribution of the ascorbic acid provided by citrus-based juices is well known [35].
The ascorbic acid content of our juice was 30 mg/100 mL [36]. Iron absorption may have been
enhanced slightly by high intake of ascorbic acid from our test ACJ; the mild increase in plasma
hepcidin observed after ACJ intervention might be a consequence of a mild increment in the iron
status of the organism. In this sense, further studies are needed to evaluate the real contribution of
the different nutrients of juices, especially vitamin C, to hepcidin levels in order to provide advice
regarding their intake in sport nutrition.
Finally, the serum ferritin concentration can be used to evaluate iron stores and it has been
correlated with hepcidin in the general population [37], in elderly people [38], and in children [39].
We observed a tendency of the plasma ferritin levels to decrease in our triathletes during the training
(data not shown), due to decreases in the iron levels. This effect has also been observed during
the long-term training of runners [40]. Hence, the lower level of plasma iron due to exercise might
attenuate an increase in hepcidin, as a homeostatic response.
4. Materials and Methods
4.1. Chemicals
The Dynabeads® MyOneTM Carboxylic Acid magnetic particles were obtained from Invitrogen
(Life Technologies, Van Alley, CA, USA). The hepcidin standard was obtained from Peptide Institute
Inc. (Osaka, Japan), N-ethyl-N′-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and
2-(N-morpholino)-ethane sulfonic acid (MES) from Calbiochem® (Merck, Madrid, Spain), and
phosphate-buffer saline (PBS) from Sigma Aldrich (Madrid, Spain). The solvents used, such as
formic acid and acetonitrile, were LC-MS grade and were purchased from Panreac (Castelar del
Vallés, Barcelona, Spain). The ultra-high quality (UHQ) water was produced using a Millipore water
purification system (Madrid, Spain).
4.2. Instrumental—UHPLC-MS/MS Analysis
Chromatographic analyses of hepcidin levels in plasma were carried out with an ultra-high
performance liquid chromatograph (UHPLC) coupled to a 6460 QqQ-MS/MS (triple quadrupole mass
spectrometer) (Agilent Technologies, Waldbronn, Germany) equipped with an electrospray ionization
(ESI) source. The method was based on that previously published by Bansal et al. [16], with some
modifications. The separation of hepcidin was performed on an Acquity UPLC HSS T3 column (1.8 µm,
2.1 mm × 100 mm) (Waters, Milford, MA, USA). The mobile phases used were 0.1% formic acid in
deionized H2O (A) and 0.1% formic acid in acetonitrile (B). The gradient started with 15% B, reached
90% B at 3 min, was maintained at 90% B for 5 min, and changed to 15% B at 5.01 min. The flow rate
and injection volume were 0.2 mL·min−1 and 3 µL, respectively. The temperature of the column was
maintained at 45 ◦C.
The mass spectrometry (MS) analysis was performed in the multiple reaction monitoring (MRM)
ESI positive mode. The source optimized parameters were as follows: gas temperature: 300 ◦C,
sheath gas temperature: 300 ◦C, sheath gas flow: 10 L·min−1, gas flow: 13 L·min−1, capillary voltage:
4500 V, and nebulizer pressure: 40 psi. The delta EMV was 400. The dwell time was 200 ms for all
MRM transitions.
Data acquisition and processing were performed using MassHunter software version B.04.00
(Agilent Technologies).
Detection and quantification were performed using standard calibration curves of hepcidin at
concentrations between 0.05 and 100 nM. For this purpose, we prepared different concentrations of
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standard hepcidin spiked in plasma and we followed the same protocol of extraction with the beads as
for the test samples that were measured.
4.3. Extraction of Hepcidin from Human Plasma
Plasma samples (200 µL) were extracted for hepcidin purification and quantification. Plasma
proteins were precipitated with two volumes of cold acetonitrile, the mixtures were centrifuged at
12,000× g for 10 min, and the whole supernatant was collected for analysis. Acetonitrile precipitates
proteins and high-molecular-weight peptides whilst it does not affect hepcidin—which remains in
the supernatant [41,42]. The concentration of total proteins was determined by the Bradford test,
to optimize hepcidin extraction [43].
The subsequent extraction was performed according to the method of Bansal et al. [16], with some
modifications. We employed Dynabeads® MyOneTM Carboxylic Acid nanoparticles (Invitrogen) to
specifically capture molecules that are protein in nature. These beads are superparamagnetic, spherical
particles, 1 µm in diameter and coated with carboxylic groups on the surface. Their small size, with
a high surface area per mg, corresponds to a high ligand capacity. A carbodiimide is used to activate
these beads, for amide bonding with primary amines of the peptide. After incubation, to allow affinity
capture of hepcidin, the beads are applied to a magnet. The unwanted supernatant is removed and the
beads washed to give the pure compound. The target hepcidin is eluted off the beads with conventional
elution methods.
The effective isolation of the target molecule using magnetic beads is dependent on the
bead concentration, target molecule size and concentration, the ligand′s affinity for the target
molecule, concentration of total proteins, buffer used, and specific binding kinetics involved. Hence,
we optimized the relative concentrations of each reagent and the quantity of plasma used and scaled
the volumes needed for the best isolation of the target hepcidin from plasma samples.
After activation of the Dynabeads® MyOneTM Carboxylic Acid, following the manufacturer′s
instructions, 100 µL were transferred to a 1.5-mL tube and left on the magnet for 2 min. After removing
the supernatant, we added 120 µL of 15 mM MES buffer, pH 6.0, and vortexed the mixture.
The supernatant was then removed by aspiration after a 2-min placement on the magnet. This MES
buffer addition step was then repeated. The beads were re-suspended in 20 µL of 15 mM MES
buffer, pH 6.0, activated with 20 µL of EDC (10 mg/mL), and incubated on a roller for 30 min at
room temperature. Then, the tube was placed on the magnet for 2 min to remove the supernatant.
The activated beads were added to the deproteinized sample plus 400 µL of 15 mM MES buffer, pH 6.0.
The mixture was incubated on the roller for a minimum of 3 h.
The tube was left on the magnet for 2 min, to remove unbound proteins. A washing step
was performed with 120 µL of PBS in 0.5% (v/v) Tween-20, by incubation on a roller for 10 min,
followed by supernatant aspiration as described above. This step was repeated. Finally, the target
compound—hepcidin—was eluted from the magnetic nanoparticles in 200 µL of acetonitrile/0.1%
formic acid (1:4, v/v).
The efficacy of the extraction of hepcidin was tested at concentrations of 0.5 nM, 5 nM, and 10 nM,
which are within the range of the values reported in the literature [16,22,42,44–46]. Hepcidin solution
(20 µL) was added to the plasma before extraction with the beads, whilst in parallel another sample
of plasma underwent extraction and then the same amount of hepcidin was added. The percentage
recovery was calculated as (AreaPRE/AreaPOST) × 100, where AreaPRE represents the samples with
hepcidin added before bead treatment and AreaPOST the samples with hepcidin added after bead
treatment. The values obtained were above 90% in all cases.
4.4. Dietary Intervention
The functional aronia-citrus juice (ACJ) included in this study was a mixture of fresh citrus
juice (95%) and 5% aronia extract (Aronia melanocarpa), based on a drink model developed before
and reported by Gonzalez-Molina et al. [36]. The juice was produced on an industrial pilot scale
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by a company in the Murcia region [27]. The nutritional composition of the ACJ was: energy
38 kcal/100 mL; protein 0.45 g/100 mL; carbohydrates 9 g/100 mL; fat 0.03 g/100 mL. The vitamin C
content of the juice was 30 mg per 100 mL. The contents of fruit flavonoids, hydroxycinnamates, and
catechins are summarized in Table 2 [36].
The placebo beverage composition was based on a mixture of water, authorized red dye, flavoring
agent, and sweetener. Its sensory characteristics were adjusted so that they were similar to those of
the ACJ.
Table 2. Phenolic composition of aronia-citrus juice (per 100 mL).
Mean SD
Flavanones (mg)
Eriocitrin 11.45 0.08
Hesperidin 13.54 0.14
Flavones (mg)
Diosmetin-6,8-di-O-glucoside 7.75 0.19
Diosmin <0.25
Vicenin-2 0.59 0.02
Anthocyanins (mg)
Cyanidin 3-O-glucoside 1.31 0.02
Cyanidin 3-O-arabinoside 9.19 0.20
Cyanidin 3-O-galactoside 15.08 0.10
Cyanidin 3-O-xyloside 1.11 0.03
Total Anthocyanins 26.70 0.35
Hydroxycinnamic acids (mg)
Neochlorogenic acid 19.72 0.17
Chlorogenic acid 14.69 0.13
Σ Quercetin derivatives * (mg) 4.31 0.13
* Quercetin derivatives were quantified as the sum of quercetin 3-O-galactoside, quercetin-3-O-glucoside, and
quercetin-3-O-rutinoside.
4.5. Sample Collection and Design of the Study
The individuals involved in the sample collection were 16 Caucasian triathletes (six amateur
training women and 10 elite training men), aged 19–21 years, from the University of Alicante (Alicante,
Spain). They were non-smokers, had stable food habits, and did not receive any medication during
the study. This study was conducted according to the guidelines laid down in the Declaration of
Helsinki and all procedures involving human subjects were approved by the Bioethics Committee
of the University Hospital of Murcia. Written, informed consent was obtained from all subjects.
This study followed a randomized, double-blind, placebo-controlled crossover design (Figure 3).
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Total Anthocyanins 26.70 0.35 
Hydroxycinn mic acids (mg)   
Neochlorogenic acid 19.72 0.17 
Chlorogenic acid 14.69 0.13 
Σ Quercetin derivatives * (mg) 4.31 0.13 
* Quercetin derivatives were quantified as the sum of quercetin 3-O-galactoside, quercetin-3-O-glucoside, 
and querceti -3-O-rutinosid . 
4.5. Sample Collection and Design of the Study 
The individuals involved in the sample collection were 16 Caucasian triathletes (six amateur 
training women and 10 elite training men), aged 19–21 years, from the University of Alicante 
(Alicante, Spain). They were non-s okers, had stable food habits, and did not receive any 
medication during the study. This study was conducted according to the guidelines laid down in the 
Declaration of Helsinki and all procedures involving human subjects were approved by the 
Bioethics Committee of the University Hospital of Murcia. Written, informed consent was obtained 
from all subjects. This study followed a randomized, double-blind, placebo-controlled crossover 
design (Figure 3). 
 
Figure 3. Study design. 
The study design has been described previously and approved for the determination of the 
influence of ACJ on the generation of DNA oxidation catabolites [27]. Plasma samples as controls 
were collected before the diet supplementation with ACJ. The first control, baseline plasma, was 
collected after 15 days of training with minimal ECO loads (37.5 ± 5.5). The second control plasma 
was collected after a 15-day training of increased ECO loads (1008 ± 105) and this increase in ECO 
load was maintained until the end of the study. In the next stage, with the dietary intervention, the 
subjects were randomly divided into two groups and supplemented with either 200 mL of ACJ or 
200 mL of placebo drink per day, for 45 days. Every day the intake of the drink took place 15 min 
Figure 3. Study design.
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The study design has been described previously and approved for the determination of the
influence of ACJ on the generation of DNA oxidation catabolites [27]. Plasma samples as controls
were collected before the diet supplementation with ACJ. The first control, baseline plasma, was
collected after 15 days of training with minimal ECO loads (37.5 ± 5.5). The second control plasma
was collected after a 15-day training of increased ECO loads (1008± 105) and this increase in ECO load
was maintained until the end of the study. In the next stage, with the dietary intervention, the subjects
were randomly divided into two groups and supplemented with either 200 mL of ACJ or 200 mL
of placebo drink per day, for 45 days. Every day the intake of the drink took place 15 min after the
athletes had finished their training, in order to improve the bioavailability of the phytochemicals from
the ACJ [15]. After each intervention, 10 days were utilized as a washout period without drink intake,
but the training was maintained. Subsequently, the intervention protocol was repeated, swapping the
two groups according to the corresponding drink intake while maintaining their training (same ECOs).
Afterwards, there was an ultimate phase of the study: 15 days without supplementation and with
decreases of ECOs (control post-treatment).
Blood samples were collected at the end of each period in heparin sampling tubes, and centrifuged
to separate the plasma from the cells.
The volunteers consumed a constant diet during the entire intervention, until its conclusion,
to avoid any interference of the diet with the oxidative stress events. The diet was accurately
designed and overviewed by nutritionists, using specific software for the calculation of the dietary
parameters and caloric intake. The subjects were instructed to eat only the food provided to them by the
nutritionists. Daily and weekly averages of the 24-h caloric intake were calculated (Table 3). The data
were calculated using software available on the website http://www.easydiet.es, with the additional
assistance of the Spanish (http://www.bedca.net/) and United States Department of Agriculture
(USDA) (http://www.nal.usda.gov/fnic/foodcomp/search/) databases. All food for the study was
prepared and weighed to achieve the desired and constant caloric level and intake of nutrients for
each triathlete.
Table 3. Dietary parameters and caloric intake of the triathletes during the study.
Mean SD
Energy intake (kcal·d−1) 2446.3 528.5
Carbohydrate (g·d−1) 268.7 81.2
Dietary fibre (g·d−1) 21.4 8.3
Sugar (g·d−1) 100.9 28.8
Proteins (g·d−1) 108.5 35.6
Total lipids (g·d−1) 110.4 4.7
SFA a (g·d−1) 31.6 2.8
MUFA b (g·d−1) 56.7 0.1
PUFA c (g·d−1) 16.4 0.7
Vitamin C (mg·d−1) 156.9 30.9
Vitamin A (µg·d−1) 2198.7 1090.8
Vitamin E (mg·d−1) 17.5 5.0
Vitamin D (mg·d−1) 869.9 167.2
Iron (mg·d−1) 17.9 4.2
Selenium (mg·d−1) 126.4 33.1
a Saturated fatty acids; b Monounsaturated fatty acids; c Polyunsaturated fatty acids.
Anthropometric measurements, achieved according to the International Society of Advancement
of Kinanthropometry (ISAK), were performed by the same, internationally-certified anthropometrist
(level 2 ISAK), as described in Medina et al. [25].
The quantification of the training program was addressed to evaluate its effects on physiological
adaptation and subsequent performance. In our work, the training load quantification was performed
using the “objective-load scale” (ECOs) developed by Cejuela Anta and Esteve-Lanao [47]. The training
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load that a triathlete supports is an indication of his/her performance level. The method used allowed
the quantification of the training loads in the sport of triathlon (swim, bike, run, and transitions),
which are determined by the difficulty in maintaining technique, delayed muscle soreness, typical
workout density, and energy cost of each separate sport. The values of daily and weekly trainings
were determined and summarized to assess the training load (ECOs) of each volunteer, depending on
their physical characteristics and the intensity of the training program (Table 4).
Table 4. Baseline physical characteristics of the triathletes (n = 16).
Mean SD
Weight (kg) 62.3 10.5
Height (m) 1.7 0.1
BMI a (kg·m−2) 21.7 0.7
Total fat (kg) 9.0 0.4
Lean weight (kg) 26.1 7.5
Subescapular skinfold (mm) 11.2 2.2
Tricipital skinfold (mm) 12.6 5.2
Bicipital skinfold (mm) 7.9 3.5
Ileocrestal skinfold (mm) 15.9 5.4
Supraespinal skinfold (mm) 11.7 3.7
Abdominal skinfold (mm) 19.8 4.7
Thigh skinfold (mm) 21.1 8.7
Calf skinfold (mm) 11.9 4.1
a Body mass index.
The “amateur athlete” term in this study refers to athletes that have a daily training load slightly
lower than that of the elite athletes and a shorter time of training, but they have been monitored by
a nutritionist and by a specialist in sport, so they are not the “amateur” that we commonly consider.
Amateur training was performed by women, due to their intrinsic physiology (women on menstrual
days could not follow an elite training schedule), and men followed an elite training schedule.
One limitation of the study is that we have combined the data of both genders and both types of
training due to sample size reasons; amateur training is a very specific training load, with an exhaustive
control of the volunteers. This strict control of nutrition, training, and rest helped us to homogenize
the samples and decrease variability. The training was individualized for the volunteers according
to their sex and physical condition. Hence, they have been pooled as a unique population following
a very highly specialized training, in contrast with people that play sports occasionally, as a hobby,
or less intensely.
4.6. Statistical Analysis
Hepcidin levels were determined in plasma samples of triathletes as nM. Box plots with quartiles
(upper values, 75%; median, 50%; and and lower values, 25%) were generated. For the hepcidin
concentrations, a Friedman′s non-parametric repeated measure analysis of variance (ANOVA) was
used to compare the concentrations in the different groups, since the normality and/or equal variance
tests failed. When a significant difference was found in the ANOVA, a pair-wise comparison was
performed using the Wilcoxon signed-rank test with Bonferroni correction. For the statistical analyses,
an adjusted value, p < 0.005, was considered to be significant. The statistical analyses were performed
using the SPSS 17.0 software package (LEAD Technologies, Inc., Chicago, IL, USA).
5. Conclusions
Long-term, regular, and repetitive training caused significant decreases in the plasma hepcidin
concentrations in elite triathletes. This effect may have arisen from a decrease in the inflammation
status due to the long-term training, as well as being a homeostatic response to the decreased levels
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of iron—in order to enhance the absorption of this mineral. The ingestion of a juice made with
aronia extract and citrus juice, rich in polyphenols, did not significantly affect the plasma hepcidin
concentration, or at least not at the selected dose (200 mL). The high ascorbic acid content of this
juice might attenuate the effect of polyphenols on iron absorption. Thus, this study—as a preliminary
experiment—could help to design specialised sport food, like fruit juices or smoothies, to achieve
a well-balanced diet in triathletes. Further studies are required to ascertain the time and conditions
necessary to restore hepcidin levels, which reflect the iron status of triathletes.
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